WhaleCreepWhat the best hedge funds own, from their SEC 13F filings
HomeFundsValueAct Capital › Q2 2009

ValueAct Capital 13F holdings, Q2 2009

Holdings as of June 30, 2009 · filings on SEC EDGAR · latest filing →

ValueAct Capital disclosed 13 US equity positions worth $2.1bn in its Q2 2009 13F filing. The largest position was VALEANT PHARMACEUTICALS INTL at 20.7% of the reported book, followed by THOMSON REUTERS CORP and SARA LEE CORP. Against the Q1 2009 filing, it opened 6 new positions, added to 2 and reduced 1 among the top 13 holdings.

← Q1 2009 · Q3 2009 →

What did ValueAct Capital own in Q2 2009? Top 13 positions

#StockSectorWeightValueSharesΔ sharesvs Q1 2009
1 VALEANT PHARMACEUTICALS INTL 20.7%$438.0m17,028,993 29% added
2 THOMSON REUTERS CORP 16.3%$346.5m12,150,142 11% added
3 SARA LEE CORP 16.1%$340.7m34,909,567 0% held
4 IT GARTNER GROUP INC NEW-CL A Technology 15.0%$317.3m20,790,013 0% held
5 EFX EQUIFAX INC Industrials 11.8%$250.3m9,588,659 0% held
6 BFH ALLIANCE DATA SYSTEM CORP Financial Services 7.2%$152.9m3,712,818 -10% reduced
7 MDS INC 5.8%$123.4m23,107,700 0% held
8 WILLIS GROUP HOLDINGS LTD 4.2%$88.4m3,435,110 new
9 IMMUCOR INC 1.3%$27.5m2,000,000 new
10 SAFEWAY INC 0.6%$13.7m673,300 new
11 INTERATCIVE DATA CORP 0.6%$13.2m569,986 new
12 STARWOOD HOTELS&RESORTS WRLD 0.2%$4.4m200,000 new
13 DENTSPLY INTL INC NEW 0.2%$3.4m110,048 new

Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.